Medical risk assessment method and program product

• US 7,306,562 B1
• Filed: 04/23/2004
• Issued: 12/11/2007
• Est. Priority Date: 04/23/2004
• Status: Active Grant

• Current Assignee: Medical Software, LLC
• Original Assignee: Medical Software, LLC
• Inventors: Baykal, Demir
• Primary Examiner(s): Marmor, II, Charles A.
• Assistant Examiner(s): Toth, Karen E
• Application Number:
  US10/831,481
• Time in Patent Office: 1,327 Days
• Field of Search: 600/300, 600/481
• US Class Current: 600/481
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/30 relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment
• CPC Class Codes: G16H 70/20 relating to practices or guidelines

Abstract

A medical risk assessment method and computer program product resident on a computer or a hand-held device that allows a physician to determine the best strategy for primary and secondary cardiovascular disease prevention utilizing current guidelines and published medical literature. The computer program product evaluates a number of risk factors to determine specific recommendations for an individual patient, including Framingham risk scoring (FRS), pertinent medical history, individual lipid panel and advanced lipoprotein profiling, patient laboratory test results, and published literature on the effects of anti-lipid medicines on plasma concentration and/or composition of lipoprotein molecules and clinical outcomes. The risk assessment method establishes a cardiovascular treatment therapy strategy for a patient by determining a cardiac risk classification group, determining a cardiovascular treatment therapy based on the patient'"'"'s lipoprotein profile and the patient'"'"'s cardiac group risk classification, and presenting the cardiovascular treatment therapy for the patient to a medical practitioner on a patient evaluation display.

Claims

1. A computer-implemented method for establishing a cardiovascular treatment therapy strategy for a patient, comprising the steps of:

determining a cardiac risk classification group for the patient based on a predetermined set of cardiac risk factors;

determining a cardiovascular treatment therapy based on the patient'"'"'s determined cardiac group risk classification and lipoprotein profile; and

presenting the determined cardiovascular treatment therapy for the patient to a medical practitioner on a patient evaluation display.

2. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 1 wherein the predetermined set of cardiac risk factors comprises a first subset and a second subset of cardiac risk factors.

3. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 2 wherein the first subset of cardiac risk factors includes coronary heart disease, peripheral vascular disease, type II diabetes mellitus, an abdominal aortic aneurysm and symptomatic carotid disease.

4. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 2 wherein the second subset of cardiac risk factors includes a patient'"'"'s age, a smoking status, a family history of cardiac disease, a diagnosis of systolic arterial hypertension and a systolic blood pressure treated condition.

5. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 1 wherein the step of determining a cardiac risk classification group comprises evaluation of the patient'"'"'s medical history to determine if the patient has at least one medical condition in a first subset of cardiac risk factors.

6. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 5 wherein the step of determining a cardiac risk classification group further comprises determining a Framingham risk score for the patient.

7. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 5 wherein the step of determining a cardiac risk classification group further comprises evaluation of the patient'"'"'s medical history to determine if the patient has at least two medical conditions in a second subset of cardiac risk factors.

8. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 5 wherein the patient is classified in a first risk classification group if the patient has at least one medical condition in a first subset of cardiac risk factors.

9. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 6 wherein the patient is classified in a first risk classification group if the patient has a Framingham risk score greater than 15.

10. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 7 wherein the patient is classified in a separate risk classification group if the patient has at least two medical conditions in the second subset of cardiac risk factors and has a Framingham risk score less than 12.

11. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 7 wherein the patient is classified in a separate risk classification group if the patient has at least two medical conditions in the second subset of cardiac risk factors and has a Framingham risk score of 12 or greater.

12. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 7 wherein the patient is classified in a separate risk classification group if the patient has less than two medical conditions in the second subset of cardiac risk factors.

13. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 5 wherein the first subset of cardiac risk factors includes coronary heart disease, peripheral vascular disease, type II diabetes mellitus, an abdominal aortic aneurysm and symptomatic carotid disease.

14. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 5 wherein the second subset of cardiac risk factors includes a patient'"'"'s age, a smoking status, a family history of cardiac disease, a diagnosis of systolic arterial hypertension and a systolic blood pressure treated condition.

15. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 1 wherein the cardiac group risk classification group and cardiovascular treatment therapies are based on published medical guidelines and published medical literature.

16. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 15 wherein the published medical literature includes the effects of anti-lipid medicines on plasma concentration.

17. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 15 wherein the published medical literature includes the effects of anti-lipid medicines on composition of lipoprotein molecules and clinical outcomes.

18. The computer-implemented method for establishing a cardiovascular treatment therapy strategy of claim 1 further comprising presenting a medical guidelines recommendation for the patient to the medical practitioner on the patient evaluation display.

19. A computer program product for establishing a cardiovascular treatment therapy strategy, the computer program product comprising:

a recording medium;

program instructions recorded on the recording medium for determining a cardiac risk classification group for the patient based on a predetermined set of cardiac risk factors;

program instructions recorded on the recording medium for determining a cardiovascular treatment therapy based on the patient'"'"'s cardiac group risk classification and lipoprotein profile; and

program instructions recorded on the recording medium for presenting the determined cardiovascular treatment therapy for the patient to a medical practitioner on a patient evaluation display.

20. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 19 wherein the program instructions for determining a cardiac risk classification group comprise program instructions for evaluation of the patient'"'"'s medical history to determine if the patient has at least one medical condition in a first subset of cardiac risk factors.

21. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 20 wherein program instructions for determining a cardiac risk classification group further comprise program instructions for determining a Framingham risk score for the patient.

22. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 20 wherein the program instructions for determining a cardiac risk classification group further comprise program instructions for evaluation of the patient'"'"'s medical history to determine if the patient has at least two medical conditions in a second subset of cardiac risk factors.

23. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 20 further comprising program instructions for classifying the patient in a first risk classification group if the patient has at least one medical condition in a first subset of cardiac risk factors.

24. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 21 further comprising program instructions for classifying the patient in a first risk classification group if the patient has a Framingham risk score greater than 15.

25. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 22 further comprising program instructions for classifying the patient in a separate risk classification group if the patient has at least two medical conditions in the second subset of cardiac risk factors and has a Framingham risk score less than 12.

26. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 22 further comprising program instructions for classifying the patient in a separate risk classification group if the patient has at least two medical conditions in the second subset of cardiac risk factors and has a Framingham risk score of 12 or greater.

27. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 22 further comprising program instructions for classifying the patient in a separate risk classification group if the patient has less than two medical conditions in the second subset of cardiac risk factors.

28. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 20 wherein the first subset of cardiac risk factors includes coronary heart disease, peripheral vascular disease, type II diabetes mellitus, an abdominal aortic aneurysm and symptomatic carotid disease.

29. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 20 wherein the second subset of cardiac risk factors includes a patient'"'"'s age, a smoking status, a family history of cardiac disease, a diagnosis of systolic arterial hypertension and a systolic blood pressure treated condition.

30. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 19 wherein program instructions for determining the cardiac group risk classification group and program instructions for determining cardiovascular treatment therapies are based on published medical guidelines and published medical literature.

31. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 30 wherein the published medical literature includes the effects of anti-lipid medicines on plasma concentration.

32. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 30 wherein the published medical literature includes the effects of anti-lipid medicines on composition of lipoprotein molecules and clinical outcomes.

33. The computer program product for establishing a cardiovascular treatment therapy strategy of claim 19 further comprising presenting a medical guidelines recommendation for the patient to the medical practitioner on the patient evaluation display.